SK280185B6 - Transdermálny terapeutický systém na podávanie fyz - Google Patents

Transdermálny terapeutický systém na podávanie fyz Download PDF

Info

Publication number
SK280185B6
SK280185B6 SK593-95A SK59395A SK280185B6 SK 280185 B6 SK280185 B6 SK 280185B6 SK 59395 A SK59395 A SK 59395A SK 280185 B6 SK280185 B6 SK 280185B6
Authority
SK
Slovakia
Prior art keywords
transdermal therapeutic
physostigmine
therapeutic system
reservoir layer
layer
Prior art date
Application number
SK593-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK59395A3 (en
Inventor
Lothar Deurer
Thomas Hille
Thomas Profitlich
Fritz Stanislaus
Kersten Walter
Original Assignee
Lts Lohmann Therapie-Systeme Gmbh And Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie-Systeme Gmbh And Co. Kg filed Critical Lts Lohmann Therapie-Systeme Gmbh And Co. Kg
Publication of SK59395A3 publication Critical patent/SK59395A3/sk
Publication of SK280185B6 publication Critical patent/SK280185B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
SK593-95A 1992-11-12 1993-10-27 Transdermálny terapeutický systém na podávanie fyz SK280185B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4238223A DE4238223C1 (de) 1992-11-12 1992-11-12 Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung
PCT/EP1993/002970 WO1994010999A1 (de) 1992-11-12 1993-10-27 Transdermales therapeutisches system zur verabreichung von physostigmin an die haut und verfahren zu dessen herstellung

Publications (2)

Publication Number Publication Date
SK59395A3 SK59395A3 (en) 1996-05-08
SK280185B6 true SK280185B6 (sk) 1999-09-10

Family

ID=6472735

Family Applications (1)

Application Number Title Priority Date Filing Date
SK593-95A SK280185B6 (sk) 1992-11-12 1993-10-27 Transdermálny terapeutický systém na podávanie fyz

Country Status (32)

Country Link
US (1) US5698216A (sh)
EP (1) EP0667774B1 (sh)
JP (1) JP3407073B2 (sh)
KR (1) KR100254573B1 (sh)
CN (1) CN1088457A (sh)
AT (1) ATE156356T1 (sh)
AU (1) AU684256B2 (sh)
CA (1) CA2147274C (sh)
CZ (1) CZ284008B6 (sh)
DE (2) DE4238223C1 (sh)
DK (1) DK0667774T3 (sh)
EE (1) EE03135B1 (sh)
EG (1) EG20527A (sh)
ES (1) ES2105334T3 (sh)
FI (1) FI952269A (sh)
GR (1) GR3024720T3 (sh)
HR (1) HRP931391B1 (sh)
HU (1) HUT72963A (sh)
IL (1) IL107547A (sh)
LT (1) LT3107B (sh)
LV (1) LV10749B (sh)
MD (1) MD937C2 (sh)
MY (1) MY111373A (sh)
NO (1) NO306760B1 (sh)
NZ (1) NZ257136A (sh)
PL (1) PL172999B1 (sh)
RU (1) RU2108812C1 (sh)
SI (1) SI9300589A (sh)
SK (1) SK280185B6 (sh)
WO (1) WO1994010999A1 (sh)
YU (1) YU71293A (sh)
ZA (1) ZA938413B (sh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4446600A1 (de) * 1994-12-24 1996-06-27 Lohmann Therapie Syst Lts Transdermale Resorption von Wirkstoffen aus unterkühlten Schmelzen
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
DE19923551A1 (de) * 1999-05-21 2000-11-30 Lohmann Therapie Syst Lts Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht
AT500143A1 (de) * 2004-04-22 2005-11-15 Sanochemia Pharmazeutika Ag Cholinesterase-inhibitoren in liposomen sowie deren herstellung und verwendung

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3921363A (en) 1974-05-17 1975-11-25 Preston Metal & Roofing Prod Cross member with end connector
IL72684A (en) 1984-08-14 1989-02-28 Israel State Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment
DE3843238C1 (sh) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
DE3843239C1 (sh) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
US5350581A (en) * 1989-12-14 1994-09-27 Pharmetrix Corporation Method for manufacturing transdermal devices
NZ237241A (en) * 1990-03-02 1993-11-25 Pharmetrix Corp Method for increasing the storage stability of physostigmine
WO1991015176A1 (en) * 1990-04-06 1991-10-17 Pharmetrix Corporation Device and method for enhanced administration of physostigmine
JP4355469B2 (ja) * 2002-03-08 2009-11-04 日本碍子株式会社 アルミナ担持担体、触媒体及びアルミナ担持担体の製造方法

Also Published As

Publication number Publication date
PL308531A1 (en) 1995-08-21
FI952269A0 (fi) 1995-05-10
US5698216A (en) 1997-12-16
CZ124495A3 (en) 1996-01-17
SI9300589A (en) 1994-06-30
IL107547A0 (en) 1994-02-27
HRP931391A2 (en) 1995-02-28
NZ257136A (en) 1996-07-26
MD940311A (en) 1998-03-31
FI952269A (fi) 1995-05-10
YU71293A (sh) 1996-07-24
EP0667774B1 (de) 1997-08-06
HRP931391B1 (en) 1999-12-31
LT3107B (en) 1994-12-27
HU9501390D0 (en) 1995-06-28
ZA938413B (en) 1994-06-09
DE59307089D1 (de) 1997-09-11
JPH08502986A (ja) 1996-04-02
NO306760B1 (no) 1999-12-20
JP3407073B2 (ja) 2003-05-19
DE4238223C1 (de) 1994-05-26
LV10749B (en) 1996-06-20
MD937B2 (sh) 1998-03-31
ATE156356T1 (de) 1997-08-15
MY111373A (en) 1999-12-31
CA2147274C (en) 2005-12-13
CA2147274A1 (en) 1994-05-26
CZ284008B6 (cs) 1998-07-15
SK59395A3 (en) 1996-05-08
KR950703948A (ko) 1995-11-17
EP0667774A1 (de) 1995-08-23
LV10749A (lv) 1995-08-20
RU2108812C1 (ru) 1998-04-20
PL172999B1 (pl) 1998-01-30
DK0667774T3 (da) 1998-03-23
HUT72963A (en) 1996-06-28
WO1994010999A1 (de) 1994-05-26
EE03135B1 (et) 1998-12-15
NO951864L (no) 1995-05-11
CN1088457A (zh) 1994-06-29
NO951864D0 (no) 1995-05-11
IL107547A (en) 1996-12-05
GR3024720T3 (en) 1997-12-31
KR100254573B1 (ko) 2000-05-01
ES2105334T3 (es) 1997-10-16
LTIP1469A (en) 1994-06-15
AU5338594A (en) 1994-06-08
AU684256B2 (en) 1997-12-11
EG20527A (en) 1999-06-30
MD937C2 (ro) 1999-01-31

Similar Documents

Publication Publication Date Title
KR100300477B1 (ko) 활성성분으로서 갈란타민을 포함하는 경피치료시스템
KR950015058B1 (ko) 활성 성분으로 피소스티그민을 함유하는 경피 치료 시스템 및 그 제조방법
US8962014B2 (en) Transdermal therapeutic system for administering rivastigmine or derivatives thereof
JP2655983B2 (ja) チロシナーゼ抑制活性を有する薬物の安定性を改善する方法、及び、皮膚美白用貼付剤
CA2041330C (en) Percutaneously absorbable eperisone or tolperisone preparation
CN112915071A (zh) 一种含有美金刚的透皮贴剂
SK280185B6 (sk) Transdermálny terapeutický systém na podávanie fyz
JPH07103016B2 (ja) 貼付剤およびその製造方法
US10076502B2 (en) Transdermal therapeutic system for administering rivastigmine or derivatives thereof
JPH01233212A (ja) 貼付剤
EP0742716B1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
JPH0753671B2 (ja) 経皮・経粘膜製剤
KR20040044907A (ko) 에날라프릴 에스테르의 경피 투여
KR19990077110A (ko) 17-β-에스트라디올을 인체로 방출하기 위한 피부 접착용 약제
JPH062666B2 (ja) 貼付剤
EP1043979B1 (en) Compositions for the transdermal and dermal administration of biologically active agents
EP0544900A1 (en) Transdermal nicotine absorption dosage unit and process
KR20020066047A (ko) 케토프로펜을 함유하는 경피투여 조성물과 이를 포함하는매트릭스형 경피투여 첩부제